Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

D. Przepiorka, N. A. Kernan, C. Ippoliti, E. B. Papadopoulos, S. Giralt, I. Khouri, J.-G. Lu, J. Gajewski, A. Durett, K. Cleary, R. Champlin, B. S. Andersson, S. Light

Blood (2000) 95 (1): 83–89.

https://doi.org/10.1182/blood.V95.1.83

Published: 2000

Journal Articles

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

D Przepiorka, C Ippoliti, I Khouri, M Woo, R Mehra, D Le Bherz, S Giralt, J Gajewski, H Fischer, H Fritsche, AB Deisseroth, K Cleary, R Champlin, K Besien, B Andersson, R Maher, W Fitzsimmons

Blood (1996) 88 (11): 4383–4389.

https://doi.org/10.1182/blood.V88.11.4383.4383

Published: 1996

Journal Articles

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (9): 3663–3664.

https://doi.org/10.1182/blood.V88.9.3663.bloodjournal8893663

Published: 1996

Journal Articles

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (8): 2819–2825.

https://doi.org/10.1182/blood.V88.8.2819.bloodjournal8882819

Published: 1996

Journal Articles

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

JW Fay, JR Wingard, JH Antin, RH Collins, LA Pineiro, BR Blazar, R Saral, BE Bierer, D Przepiorka, WE Fitzsimmons, RM Maher, DJ Weisdorf

Blood (1996) 87 (8): 3514–3519.

https://doi.org/10.1182/blood.V87.8.3514.bloodjournal8783514

Published: 1996

Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka

Blood (1995) 86 (7): 2842–2848.

https://doi.org/10.1182/blood.V86.7.2842.2842

Published: 1995

Journal Articles

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

M Korbling, D Przepiorka, J Gajewski, RE Champlin, KW Chan

Blood (1995) 86 (3): 1235.

https://doi.org/10.1182/blood.V86.3.1235.1235

Published: 1995

Journal Articles

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

M Korbling, D Przepiorka, YO Huh, H Engel, K van Besien, S Giralt, B Andersson, HD Kleine, D Seong, AB Deisseroth

Blood (1995) 85 (6): 1659–1665.

https://doi.org/10.1182/blood.V85.6.1659.bloodjournal8561659

Published: 1995

Journal Articles

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

MA Dimopoulos, R Alexanian, D Przepiorka, J Hester, B Andersson, S Giralt, R Mehra, K van Besien, KB Delasalle, C Reading

Blood (1993) 82 (8): 2324–2328.

https://doi.org/10.1182/blood.V82.8.2324.2324

Published: 1993

Journal Articles

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? [see comments]

MM Horowitz, D Przepiorka, RE Champlin, RP Gale, A Gratwohl, RH Herzig, HG Prentice, AA Rimm, O Ringden, MM Bortin

Blood (1992) 79 (10): 2771–2774.

https://doi.org/10.1182/blood.V79.10.2771.2771

Published: 1992

Journal Articles

Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia

BD Nelkin, D Przepiorka, PJ Burke, ED Thomas, SB Baylin

Blood (1991) 77 (11): 2431–2434.

https://doi.org/10.1182/blood.V77.11.2431.2431

Published: 1991

Journal Articles

Autologous bone marrow transplantation with 4- hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse

C Rosenfeld, RK Shadduck, D Przepiorka, KF Mangan, M Colvin

Blood (1989) 74 (3): 1159–1164.

https://doi.org/10.1182/blood.V74.3.1159.1159

Published: 1989

Journal Articles

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma

N Phillips, S Jacobs, R Stoller, M Earle, D Przepiorka, RK Shadduck

Blood (1989) 74 (1): 26–34.

https://doi.org/10.1182/blood.V74.1.26.26

Published: 1989

NARROW

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? [see comments]

Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia

Autologous bone marrow transplantation with 4- hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only